List of All Articles with Tag 'novob dc'

Wall Street’s enthusiasm for all things weight-loss related got a fresh boost Tuesday after results for a Novo

Novo Nordisk A/S shares surged to a record after the Danish company’s blockbuster obesity medicine Wegovy reduced the

Eli Lilly & Co. will acquire closely held Versanis Bio, a startup developing a drug for obesity and

Novo Nordisk A/S’s weight-loss medications are under investigation by the European Union’s drugs regulator after a small number

Novo Nordisk A/S sued US pharmacies making and selling versions of semaglutide, the active ingredient in Wegovy, the

Two years and more than a million prescriptions after Wegovy first went on sale, there’s one taboo question

Problems at a Catalent Inc. production facility led US regulators to deny a key drug application from Regeneron

Obesity shots like Wegovy are already a cultural phenomenon. Now it’s looking like pill forms of the drugs

An experimental weight-loss shot from Eli Lilly & Co. yielded the strongest results of any of its treatments

Pfizer Inc. is halting early development of a weight-loss drug on safety concerns, raising investor anxiety about another

Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds quickly in a mid-stage trial, setting the

Novo Nordisk A/S is spending 15.9 billion Danish kroner ($2.29 billion) to expand production facilities in Denmark as